Finance

Lists
Why is IXC up 4.76%?
Dive Deeper
IXC:ASX
Invex Therapeutics Ltd
A$0.11
+4.76%
(+0.0050) 1D
Sep 25, 4:00:00 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for IXC...
Open
A$0.11
High
A$0.11
Low
A$0.11
Mkt. cap
7.89M
Avg. vol.
29.00K
Volume
123.28K
52-wk high
A$0.16
52-wk low
A$0.09
EPS
-A$0.02
Shares outstanding
75.15M
Open
A$0.11
High
A$0.11
Low
A$0.11
Mkt. cap
7.89M
Avg. vol.
29.00K
Volume
123.28K
52-wk high
A$0.16
52-wk low
A$0.09
EPS
-A$0.02
Shares outstanding
75.15M
About Invex Therapeutics Ltd
CEO-
Employees-
Founded2019
Headquarters-
SectorPharmaceutical industry
Websiteinvextherapeutics.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
23.41K
23.41K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
63.16K
63.16K
197.04K
197.04K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
358.35K
358.35K
153.66K
153.66K
Operating expense
421.51K
421.51K
350.70K
350.70K
Total operating expenses
421.51K
421.51K
350.70K
350.70K
Operating income
-421.51K
-421.51K
-327.29K
-327.29K
Other non operating income
31.87K
31.87K
-23.41K
-23.41K
EBT including unusual items
-357.79K
-357.79K
-318.38K
-318.38K
EBT excluding unusual items
-357.79K
-357.79K
-318.38K
-318.38K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-357.79K
-357.79K
-318.38K
-318.38K
Net profit margin
-
-
-1,359.86%
-1,359.86%
Earnings per share
-
-
-
-
Interest and investment income
31.85K
31.85K
32.32K
32.32K
Interest expense
-
-
-
-
Net interest expenses
31.85K
31.85K
32.32K
32.32K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps